| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/17/2008 | US20080089881 Using nicotinic acid receptor (HM74) as diagnostic and evaluative tool in detection of psoraisis, ulcerative colitis, multiple sclerosis, irratable bowel and/or , crohn's diseases |
| 04/17/2008 | US20080089880 Fibrin sealant comprising corticosteroid for use in time released delivery of drugs, chemicals and proteins |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089878 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089862 Serine protease inhibitor for prevention and treatment of cell proliferative, liver and inflammatory disorders |
| 04/17/2008 | US20080089861 Therapeutic agent comprising memantine and dimethyl fumarate for use in prevention and treatment of autoimmune and nervous system disorders |
| 04/17/2008 | US20080089860 Such as pentamidine; cytokines; interferons; granulocyte/macrophage colony stimulating factor; for treatment of diseases associated with PTPase activity, immune deficiency, cancer, infections, hepatitis B, and hepatitis C |
| 04/17/2008 | US20080089859 Administration of sleep restorative agents |
| 04/17/2008 | US20080089858 Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
| 04/17/2008 | US20080089849 Powders for inhalation |
| 04/17/2008 | US20080089844 by opening ATP-sensitive potassium channels; circulatory, respiratory, urinary, digestive, reproductive, endocrine, or neurological organs or somatic cells; arrest, protect or preserve the heart during surgery or from reperfusion injury; administering with an adenosine receptor agonist |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | CA2791144A1 Protease screening methods and proteases identified thereby |
| 04/17/2008 | CA2683137A1 Compositions and methods for treating and diagnosing cancers |
| 04/17/2008 | CA2683127A1 Treatment of inflammation, demyelination and neuronal/axonal loss |
| 04/17/2008 | CA2673497A1 Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases |
| 04/17/2008 | CA2666536A1 Compositions and methods of using chondroitinase abci mutants |
| 04/17/2008 | CA2666511A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof |
| 04/17/2008 | CA2666466A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | CA2666344A1 Reconstituted surfactants having improved properties |
| 04/17/2008 | CA2666112A1 Pyrrolydine derivatives as iap inhibitors |
| 04/17/2008 | CA2665769A1 Composition to treat and/or prevent gastrointestinal infection |
| 04/17/2008 | CA2665691A1 Agent for therapy and/or improvement of disseminated intravascular coagulation |
| 04/17/2008 | CA2665415A1 Use of modified cyclosporins |
| 04/17/2008 | CA2665186A1 Stabilized therapeutic small helical antiviral peptides |
| 04/17/2008 | CA2664915A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | CA2603132A1 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 04/16/2008 | EP1912069A2 Method to screen ligands using eukaryotic cell display |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911789A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911788A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1911460A1 Pharmaceutical composition for promoting axonal re-growth and behaviour recovery in spinal cord injury |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1911457A1 Composition to treat or prevent gastrointestinal infection |
| 04/16/2008 | EP1910842A2 A method for detecting peptides comprising a cross-beta structure |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910829A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 04/16/2008 | EP1910567A2 Polymorphism in cysteine dioxygenase |
| 04/16/2008 | EP1910541A1 Cytotoxic ribonuclease variants |
| 04/16/2008 | EP1910539A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening |
| 04/16/2008 | EP1910535A1 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 04/16/2008 | EP1910407A2 Mutated pseudomonas exotoxins with reduced antigenicity |
| 04/16/2008 | EP1910405A2 Complement c3a derived peptides and uses thereof |
| 04/16/2008 | EP1910404A1 Hcv ns3 protease inhibitors |
| 04/16/2008 | EP1909895A2 Tandem cardiac pacemaker system |
| 04/16/2008 | EP1909842A2 Improved botulinum toxin compositions |
| 04/16/2008 | EP1909826A2 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 04/16/2008 | EP1909825A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
| 04/16/2008 | EP1909824A2 Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent |
| 04/16/2008 | EP1909823A2 Chimeric therapeutic agents |
| 04/16/2008 | EP1909822A2 Recombinant interferon alpha 2 (ifn alpha 2) mutants |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1909820A1 Modulation of granulosa cell apoptosis |
| 04/16/2008 | EP1909819A2 Receptor antagonists for treatment of metastatic bone cancer |
| 04/16/2008 | EP1909818A2 Use of bpi protein for treatment of diseases |
| 04/16/2008 | EP1909817A2 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 04/16/2008 | EP1909816A2 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 04/16/2008 | EP1909815A2 Novel biologically active peptides and their new uses |
| 04/16/2008 | EP1909814A1 Method for induction and enhancement of apoptosis in tumor cells |
| 04/16/2008 | EP1909813A2 Peptidyl diacylglycerides |
| 04/16/2008 | EP1909811A2 Gene regulation |
| 04/16/2008 | EP1909810A2 Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
| 04/16/2008 | EP1909809A2 Method and compositions for the treatment of diabetes and related complications |
| 04/16/2008 | EP1909805A1 Cell implantation to prevent and/or treat autoimmune disease |
| 04/16/2008 | EP1704414A4 Induction of apoptosis via arts-iap complexes |
| 04/16/2008 | EP1585484A4 Hepatocyte growth factor variants |
| 04/16/2008 | EP1539820B1 Ostertagia vaccine |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | EP1524988B1 Use of a proteasome inhibitor in the treatment of fibrotic diseases |
| 04/16/2008 | EP1361885B1 Use of gamma-gt inhibitors for the treatment of chronic degenerative diseases |
| 04/16/2008 | EP1309613B1 Pharmaceutical composition comprising an analgesic peptide |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP1075491B1 Pth2 receptor selective compounds |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | EP0922110B1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | EP0779806B2 Sustained release preparation containing metal salt of a peptide |
| 04/16/2008 | CN101163717A Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/16/2008 | CN101163715A A therapeutic agent for ass related disorders |
| 04/16/2008 | CN101163712A Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
| 04/16/2008 | CN101163497A Use of erythrocytes containing arginine deiminase for preparing a drug to decrease the in vivo plasma concentration of arginine |
| 04/16/2008 | CN101163496A Tropoelastin for promoting endothelial cell adhesion or migration |
| 04/16/2008 | CN101163495A Use |
| 04/16/2008 | CN101163494A Alkyl-glycoside enhanced vaccination |
| 04/16/2008 | CN101163464A Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of a GnRH |
| 04/16/2008 | CN101161677A Recombinant polypeptide having islets beta- cell protection function |
| 04/16/2008 | CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof |
| 04/16/2008 | CN101161674A Cyclopeptide, preparation method and uses thereof |
| 04/16/2008 | CN101161284A Novel antimicrobial peptides with heparin binding activity |
| 04/16/2008 | CN101161283A New use of CMTM1-v17 and its antagon |
| 04/16/2008 | CN100381570C Synovial membrane cell protein |
| 04/16/2008 | CN100381467C UreG protein, and its preparing method and sue |